Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has issued an announcement.
Charmacy Pharmaceutical Co., Ltd. has announced a final cash dividend of RMB 0.45 per share for the year ending December 31, 2024, with shareholder approval scheduled for May 22, 2025. The dividend payment is set for July 11, 2025, and will involve withholding tax rates of 10% for non-resident enterprises and individuals, and 20% for resident individuals, impacting stakeholders based on their residency status.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the distribution and sale of pharmaceutical products. The company primarily serves the healthcare sector, offering a range of medicinal products to meet market demands.
YTD Price Performance: -20.92%
Average Trading Volume: 2,000
Technical Sentiment Signal: Buy
Current Market Cap: HK$837M
For an in-depth examination of 2289 stock, go to TipRanks’ Stock Analysis page.